For better breathing, a better daily life
COPD (Chronic Obstructive Pulmonary Disease) is a debilitating respiratory disease that affects millions of people around the world. At BIKY Pharma, we are exploring innovative solutions to improve the management of COPD through treatments delivered via vaporization. This technology allows direct and effective action in the respiratory tract, reducing discomfort and symptoms to offer patients a better quality of life.
Targeted vaporization technology for maximum effectiveness
COPD causes chronic inflammation of the airways, which causes symptoms such as shortness of breath, persistent cough and a significant decrease in breathing capacity. To remedy this, BIKY Pharma relies on vaporization technology to offer rapid and targeted relief. Vaporization makes it possible to deliver the active ingredients directly to the bronchi and lungs, which is essential for rapid anti-inflammatory action. This method reduces the systemic impact of medications, which means fewer side effects compared to treatments administered orally.
A new approach to inhaled administration
For COPD, we develop vaporization solutions adapted to the needs of patients.
An integrated approach and collaborations with health professionals
At BIKY Pharma, we know that the treatment of COPD requires comprehensive care. That's why we partner with pulmonologists and other healthcare professionals to integrate our vaporization technology into personalized treatment protocols. Our goal is to improve clinical outcomes while providing a practical, easy-to-use solution that fits into patients' daily lives.
